Reduced angiotensin converting enzyme plasma activity in scleroderma. A marker of endothelial injury? 1990

M Matucci-Cerinic, and A Pignone, and T Lotti, and G Spillantini, and C Curradi, and G Leoncini, and F Iannone, and F Falcini, and M Cagnoni
Institute of Clinical Medicine IV, University of Florence, Italy.

Decreased levels of angiotensin converting enzyme plasma activity were found in systemic sclerosis. No relationship with clinical characteristics of the disease and increased von Willebrand factor antigen concentration (a widely accepted marker of endothelial injury) were statistically demonstrated. An inverse relationship between the reduced activity of the enzyme and erythrocyte sedimentation rate was detected (r = 0.410, p less than 0.05). We hypothesize that in systemic sclerosis, angiotensin converting enzyme activity might be affected by a decrease in endothelial production or by interference of circulating factors. Further studies are needed to determine if angiotensin converting enzyme activity could be used as a marker of endothelial injury in scleroderma.

UI MeSH Term Description Entries
D007703 Peptidyl-Dipeptidase A A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of ANGIOTENSIN I to ANGIOTENSIN II, with increase in vasoconstrictor activity, but no action on angiotensin II. It is also able to inactivate BRADYKININ, a potent vasodilator; and has a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. (From https://www.uniprot.org April 15, 2020). ACE1 Angiotensin-Converting Enzyme 1,ACE1 Protein,Angiotensin Converting Enzyme,Angiotensin Converting Enzyme 1,Antigens, CD143,CD143 Antigens,Dipeptidyl Carboxypeptidase I,Kininase II,Peptidase P,Angiotensin I-Converting Enzyme,Carboxycathepsin,Dipeptidyl Peptidase A,Kininase A,ACE1 Angiotensin Converting Enzyme 1,Angiotensin I Converting Enzyme,Carboxypeptidase I, Dipeptidyl,Peptidyl Dipeptidase A
D008297 Male Males
D008833 Microcirculation The circulation of the BLOOD through the MICROVASCULAR NETWORK. Microvascular Blood Flow,Microvascular Circulation,Blood Flow, Microvascular,Circulation, Microvascular,Flow, Microvascular Blood,Microvascular Blood Flows,Microvascular Circulations
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M Matucci-Cerinic, and A Pignone, and T Lotti, and G Spillantini, and C Curradi, and G Leoncini, and F Iannone, and F Falcini, and M Cagnoni
September 1992, The Journal of laboratory and clinical medicine,
M Matucci-Cerinic, and A Pignone, and T Lotti, and G Spillantini, and C Curradi, and G Leoncini, and F Iannone, and F Falcini, and M Cagnoni
June 1987, Clinical rheumatology,
M Matucci-Cerinic, and A Pignone, and T Lotti, and G Spillantini, and C Curradi, and G Leoncini, and F Iannone, and F Falcini, and M Cagnoni
June 2000, American journal of physiology. Lung cellular and molecular physiology,
M Matucci-Cerinic, and A Pignone, and T Lotti, and G Spillantini, and C Curradi, and G Leoncini, and F Iannone, and F Falcini, and M Cagnoni
March 1988, The American review of respiratory disease,
M Matucci-Cerinic, and A Pignone, and T Lotti, and G Spillantini, and C Curradi, and G Leoncini, and F Iannone, and F Falcini, and M Cagnoni
January 2006, Annales de biologie clinique,
M Matucci-Cerinic, and A Pignone, and T Lotti, and G Spillantini, and C Curradi, and G Leoncini, and F Iannone, and F Falcini, and M Cagnoni
August 1986, Archives of internal medicine,
M Matucci-Cerinic, and A Pignone, and T Lotti, and G Spillantini, and C Curradi, and G Leoncini, and F Iannone, and F Falcini, and M Cagnoni
March 1978, The Journal of clinical endocrinology and metabolism,
M Matucci-Cerinic, and A Pignone, and T Lotti, and G Spillantini, and C Curradi, and G Leoncini, and F Iannone, and F Falcini, and M Cagnoni
September 1984, The American journal of physiology,
M Matucci-Cerinic, and A Pignone, and T Lotti, and G Spillantini, and C Curradi, and G Leoncini, and F Iannone, and F Falcini, and M Cagnoni
January 1983, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde,
M Matucci-Cerinic, and A Pignone, and T Lotti, and G Spillantini, and C Curradi, and G Leoncini, and F Iannone, and F Falcini, and M Cagnoni
February 1988, Critical care medicine,
Copied contents to your clipboard!